BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19187817)

  • 1. Augmenting in vivo exposure with fear antagonistic actions: a preliminary test.
    Wolitzky KB; Telch MJ
    Behav Ther; 2009 Mar; 40(1):57-71. PubMed ID: 19187817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
    Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
    Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the judicious use of safety behaviors improve the efficacy and acceptability of exposure therapy for claustrophobic fear?
    Deacon BJ; Sy JT; Lickel JJ; Nelson EA
    J Behav Ther Exp Psychiatry; 2010 Mar; 41(1):71-80. PubMed ID: 19892318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social phobia. Longitudinal course and long-term outcome of cognitive-behavioral treatment.
    Juster HR; Heimberg RG
    Psychiatr Clin North Am; 1995 Dec; 18(4):821-42. PubMed ID: 8748383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.
    Guastella AJ; Dadds MR; Lovibond PF; Mitchell P; Richardson R
    J Psychiatr Res; 2007 Sep; 41(6):466-71. PubMed ID: 16828803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentation.
    Powers MB; Smits JA; Otto MW; Sanders C; Emmelkamp PM
    J Anxiety Disord; 2009 Apr; 23(3):350-6. PubMed ID: 19223151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific phobias.
    Hamm AO
    Psychiatr Clin North Am; 2009 Sep; 32(3):577-91. PubMed ID: 19716991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of imagery in the maintenance and treatment of snake fear.
    Hunt M; Bylsma L; Brock J; Fenton M; Goldberg A; Miller R; Tran T; Urgelles J
    J Behav Ther Exp Psychiatry; 2006 Dec; 37(4):283-98. PubMed ID: 16473325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fear activation and distraction during the emotional processing of claustrophobic fear.
    Telch MJ; Valentiner DP; Ilai D; Young PR; Powers MB; Smits JA
    J Behav Ther Exp Psychiatry; 2004 Sep; 35(3):219-32. PubMed ID: 15262218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and cognitive group treatment for fear of flying: a randomized controlled trial.
    Van Gerwen LJ; Spinhoven P; Van Dyck R
    J Behav Ther Exp Psychiatry; 2006 Dec; 37(4):358-71. PubMed ID: 16828460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
    Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
    Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial.
    Meyerbroeker K; Powers MB; van Stegeren A; Emmelkamp PM
    Psychother Psychosom; 2012; 81(1):29-37. PubMed ID: 22116378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive behavioral therapy for public-speaking anxiety using virtual reality for exposure.
    Anderson PL; Zimand E; Hodges LF; Rothbaum BO
    Depress Anxiety; 2005; 22(3):156-8. PubMed ID: 16231290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amygdala hyperfunction in phobic fear normalizes after exposure.
    Goossens L; Sunaert S; Peeters R; Griez EJ; Schruers KR
    Biol Psychiatry; 2007 Nov; 62(10):1119-25. PubMed ID: 17706612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-session treatment of specific phobias: a detailed description and review of treatment efficacy.
    Zlomke K; Davis TE
    Behav Ther; 2008 Sep; 39(3):207-23. PubMed ID: 18721635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond fear and disgust: the role of (automatic) contamination-related associations in spider phobia.
    Huijding J; de Jong PJ
    J Behav Ther Exp Psychiatry; 2007 Jun; 38(2):200-11. PubMed ID: 17125734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fear and disgust processing during repeated exposure to threat-relevant stimuli in spider phobia.
    Olatunji BO; Wolitzky-Taylor KB; Ciesielski BG; Armstrong T; Etzel EN; David B
    Behav Res Ther; 2009 Aug; 47(8):671-9. PubMed ID: 19457475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of virtual reality in acrophobia research and treatment.
    Coelho CM; Waters AM; Hine TJ; Wallis G
    J Anxiety Disord; 2009 Jun; 23(5):563-74. PubMed ID: 19282142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An experimental study of the role of vulnerability related perceptions in spider fear: comparing an imaginal and in vivo encounter.
    Armfield JM
    J Anxiety Disord; 2008; 22(2):222-32. PubMed ID: 17403597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention focusing versus distraction during exposure in dental phobia.
    Schmid-Leuz B; Elsesser K; Lohrmann T; Jöhren P; Sartory G
    Behav Res Ther; 2007 Nov; 45(11):2691-703. PubMed ID: 17719559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.